Avanos Medical has patented an adaptive multivariate control system for RF ablation procedures. The system includes an energy source, sensors, and a processor to create lesions at target sites based on multiple factors. The RF probe enhances precision in RF ablation procedures. GlobalData’s report on Avanos Medical gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights Avanos Medical Inc - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Avanos Medical, was a key innovation area identified from patents. Avanos Medical's grant share as of February 2024 was 61%. Grant share is based on the ratio of number of grants to total number of patents.

Adaptive multivariate control system for rf ablation procedures

Source: United States Patent and Trademark Office (USPTO). Credit: Avanos Medical Inc

A recently granted patent (Publication Number: US11903633B2) describes a radiofrequency (RF) ablation system designed to perform RF ablation procedures with precision and efficiency. The system includes an energy source, an energy delivery device, two or more sensors measuring factors related to the procedure, and a processor executing various operations. These operations involve creating a lesion at the target site based on specific factors, monitoring factors during energy delivery, adjusting energy levels based on thresholds, and switching control between different factors to enhance lesion development. The system aims to optimize the ablation process by ensuring factors like power, current, voltage, and tissue temperature are carefully monitored and controlled throughout the procedure.

Furthermore, the patent details a method for performing RF ablation procedures using an RF probe. The method involves delivering energy to create a lesion at the target site, monitoring operational factors related to the procedure, determining operating thresholds, and adjusting energy delivery accordingly. Additionally, the method includes collecting operational data from the RF probe, inputting this data into a deep learning network for training, and utilizing the network to control energy delivery based on the operational factors. By integrating advanced monitoring, control, and machine learning techniques, the system and method described in the patent aim to enhance the precision and effectiveness of RF ablation procedures, ultimately improving patient outcomes and procedural success rates.

To know more about GlobalData’s detailed insights on Avanos Medical, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.